Cases-Merida Sandra, Lorente-Lavirgen Ana, Pérez-Gil Amalia
Dermatology Department, Valme University Hospital, Seville, Spain.
Indian J Dermatol. 2018 May-Jun;63(3):264-267. doi: 10.4103/ijd.IJD_432_17.
Interstitial granulomatous dermatitis (IGD) was first described in 1993 by Ackerman as a cutaneous reactive disease in patients with arthritis. Since then, numerous cases associated with different hematological and rheumatic disorders have been reported. IGD is a polymorphic entity that usually involves the upper part of the trunk. Histologically, it is defined as a diffuse dermal histiocytic infiltrate of different densities surrounded by fragmented collagen. We report the case of a 56-year-old man with pruritic papules affecting neck, proximal arms and thorax associated with weight loss and chronic fatigue for six months. Two punch biopsies were taken and the specimens showed lymphohistiocytic interstitial infiltrates with fragmented collagen and elastic fibers in dermis. IGD was diagnosed as first manifestation of a rare chronic myeloproliferative hematologic disorder (cMPD) with rearrangement of beta-receptor for platelet-derived growth factor (PDGFRB). After two months of imatinib, lesions regressed completely.
间质性肉芽肿性皮炎(IGD)于1993年由阿克曼首次描述为关节炎患者的一种皮肤反应性疾病。从那时起,已报告了许多与不同血液学和风湿性疾病相关的病例。IGD是一种多形性疾病,通常累及躯干上部。组织学上,它被定义为不同密度的弥漫性真皮组织细胞浸润,周围有破碎的胶原纤维。我们报告了一例56岁男性病例,其颈部、近端手臂和胸部出现瘙痒性丘疹,并伴有体重减轻和慢性疲劳6个月。进行了两次打孔活检,标本显示真皮中有淋巴细胞组织细胞间质性浸润,伴有破碎的胶原纤维和弹性纤维。IGD被诊断为一种罕见的慢性骨髓增殖性血液疾病(cMPD)的首发表现,该疾病伴有血小板衍生生长因子(PDGFRB)β受体重排。使用伊马替尼治疗两个月后,皮损完全消退。